238 related articles for article (PubMed ID: 21438075)
1. Levodopa and the feedback process on set-shifting in Parkinson's disease.
Au WL; Zhou J; Palmes P; Sitoh YY; Tan LC; Rajapakse JC
Hum Brain Mapp; 2012 Jan; 33(1):27-39. PubMed ID: 21438075
[TBL] [Abstract][Full Text] [Related]
2. Levodopa influences striatal activity but does not affect cortical hyper-activity in Parkinson's disease.
Martinu K; Degroot C; Madjar C; Strafella AP; Monchi O
Eur J Neurosci; 2012 Feb; 35(4):572-83. PubMed ID: 22304628
[TBL] [Abstract][Full Text] [Related]
3. Levodopa-sensitive, dynamic changes in effective connectivity during simultaneous movements in Parkinson's disease.
Palmer SJ; Eigenraam L; Hoque T; McCaig RG; Troiano A; McKeown MJ
Neuroscience; 2009 Jan; 158(2):693-704. PubMed ID: 18722512
[TBL] [Abstract][Full Text] [Related]
4. Levodopa medication improves incidental sequence learning in Parkinson's disease.
Beigi M; Wilkinson L; Gobet F; Parton A; Jahanshahi M
Neuropsychologia; 2016 Dec; 93(Pt A):53-60. PubMed ID: 27686948
[TBL] [Abstract][Full Text] [Related]
5. Effects of levodopa on motor sequence learning in Parkinson's disease.
Feigin A; Ghilardi MF; Carbon M; Edwards C; Fukuda M; Dhawan V; Margouleff C; Ghez C; Eidelberg D
Neurology; 2003 Jun; 60(11):1744-9. PubMed ID: 12796524
[TBL] [Abstract][Full Text] [Related]
6. Levodopa response differs in Parkinson's motor subtypes: A task-based effective connectivity study.
Mohl B; Berman BD; Shelton E; Tanabe J
J Comp Neurol; 2017 Jun; 525(9):2192-2201. PubMed ID: 28256710
[TBL] [Abstract][Full Text] [Related]
7. Effect of levodopa on frontal-subcortical and posterior cortical functioning in patients with Parkinson's disease.
Gul A; Yousaf J
Singapore Med J; 2019 Aug; 60(8):414-417. PubMed ID: 30246215
[TBL] [Abstract][Full Text] [Related]
8. Performance of a motor task learned on levodopa deteriorates when subsequently practiced off.
Anderson ED; Horak FB; Lasarev MR; Nutt JG
Mov Disord; 2014 Jan; 29(1):54-60. PubMed ID: 24132873
[TBL] [Abstract][Full Text] [Related]
9. Task specific influences of Parkinson's disease on the striato-thalamo-cortical and cerebello-thalamo-cortical motor circuitries.
Lewis MM; Slagle CG; Smith AB; Truong Y; Bai P; McKeown MJ; Mailman RB; Belger A; Huang X
Neuroscience; 2007 Jun; 147(1):224-35. PubMed ID: 17499933
[TBL] [Abstract][Full Text] [Related]
10. Brain dopaminergic modulation associated with executive function in Parkinson's disease.
Farid K; Sibon I; Guehl D; Cuny E; Burbaud P; Allard M
Mov Disord; 2009 Oct; 24(13):1962-9. PubMed ID: 19672989
[TBL] [Abstract][Full Text] [Related]
11. Beta-band oscillations in the supplementary motor cortex are modulated by levodopa and associated with functional activity in the basal ganglia.
Chung JW; Burciu RG; Ofori E; Coombes SA; Christou EA; Okun MS; Hess CW; Vaillancourt DE
Neuroimage Clin; 2018; 19():559-571. PubMed ID: 29984164
[TBL] [Abstract][Full Text] [Related]
12. L-dopa medication in Parkinson's disease restores activity in the motor cortico-striatal loop but does not modify the cognitive network.
Jubault T; Monetta L; Strafella AP; Lafontaine AL; Monchi O
PLoS One; 2009 Jul; 4(7):e6154. PubMed ID: 19584921
[TBL] [Abstract][Full Text] [Related]
13. Focusing effects of L-dopa in Parkinson's disease.
Ng B; Palmer S; Abugharbieh R; McKeown MJ
Hum Brain Mapp; 2010 Jan; 31(1):88-97. PubMed ID: 19585587
[TBL] [Abstract][Full Text] [Related]
14. Motor loop dysfunction causes impaired cognitive sequencing in patients suffering from Parkinson's disease.
Schönberger AR; Hagelweide K; Pelzer EA; Fink GR; Schubotz RI
Neuropsychologia; 2015 Oct; 77():409-20. PubMed ID: 26382750
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic modulation of the default mode network in Parkinson's disease.
Delaveau P; Salgado-Pineda P; Fossati P; Witjas T; Azulay JP; Blin O
Eur Neuropsychopharmacol; 2010 Nov; 20(11):784-92. PubMed ID: 20674286
[TBL] [Abstract][Full Text] [Related]
16. Effects of levodopa on cognitive functioning in moderate-to-severe Parkinson's disease (MSPD).
Morrison CE; Borod JC; Brin MF; Hälbig TD; Olanow CW
J Neural Transm (Vienna); 2004 Oct; 111(10-11):1333-41. PubMed ID: 15480842
[TBL] [Abstract][Full Text] [Related]
17. Neural substrates of levodopa-responsive gait disorders and freezing in advanced Parkinson's disease: a kinesthetic imagery approach.
Maillet A; Thobois S; Fraix V; Redouté J; Le Bars D; Lavenne F; Derost P; Durif F; Bloem BR; Krack P; Pollak P; Debû B
Hum Brain Mapp; 2015 Mar; 36(3):959-80. PubMed ID: 25411130
[TBL] [Abstract][Full Text] [Related]
18. Dopamine-related dissociation of cortical and subcortical brain activations in cognitively unimpaired Parkinson's disease patients OFF and ON medications.
Kim J; Zhang K; Cai W; YorkWilliams S; Ua Cruadhlaoich MAI; Llanes S; Menon V; Poston KL
Neuropsychologia; 2018 Oct; 119():24-33. PubMed ID: 30040957
[TBL] [Abstract][Full Text] [Related]
19. Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease.
Fera F; Nicoletti G; Cerasa A; Romeo N; Gallo O; Gioia MC; Arabia G; Pugliese P; Zappia M; Quattrone A
Brain Res Bull; 2007 Sep; 74(1-3):75-83. PubMed ID: 17683792
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional gait biomechanics in Parkinson's disease: evidence for a centrally mediated amplitude regulation disorder.
Morris M; Iansek R; McGinley J; Matyas T; Huxham F
Mov Disord; 2005 Jan; 20(1):40-50. PubMed ID: 15390033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
